World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
128
Citations
82936
World Ranking
271
National Ranking
142

Medicine

D-Index
129
Citations
83915
World Ranking
2539
National Ranking
1429

Overview

Jeffrey M. Trent is affiliated with the Translational Genomics Research Institute in the United States. Their work spans multiple disciplines primarily within Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on oncology-related research.

The scientist's research encompasses numerous specialized subfields, including:

  • Molecular Biology
  • Oncology
  • Cancer Research
  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine

The main topics addressed across Jeffrey M. Trent's publications include:

  • Cancer Genomics and Diagnostics
  • Cancer Mechanisms and Therapy
  • Chromatin Remodeling and Cancer
  • Renal cell carcinoma treatment
  • Cancer Research and Treatments
  • Pancreatic and Hepatic Oncology Research
  • Cancer Immunotherapy and Biomarkers

Recent publications demonstrate engagement with various aspects of cancer and immunotherapy, featuring:

  • "Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti-PD-1 Immune Checkpoint Inhibitors" (2020, European Urology)
  • "Small-Cell Carcinoma of the Ovary, Hypercalcemic Type-Genetics, New Treatment Targets, and Current Management Guidelines" (2020, Clinical Cancer Research)
  • "Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing" (2021, Nature Biotechnology)
  • "The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer" (2020, PLoS ONE)
  • "Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis" (2020, Journal for ImmunoTherapy of Cancer)

Jeffrey M. Trent collaborates regularly with several researchers, including:

  • William P.D. Hendricks
  • Nazlı Dizman
  • Sumanta K. Pal
  • Joann Hsu
  • Sara A. Byron

The scientist has frequently published in a range of specialist venues, notably:

  • Journal of Clinical Oncology
  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research
  • Cancer Epidemiology Biomarkers & Prevention

Best Publications

  • WAF1, a potential mediator of p53 tumor suppression

    Wafik S. El-Deiry;Takashi Tokino;Victor E. Velculescu;Daniel B. Levy

  • Use of a cDNA microarray to analyse gene expression patterns in human cancer.

    Joseph L. DeRisi;Lolita Penland;Patrick O. Brown;M. L. Bittner

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

    Fredrick S. Leach;Nicholas C. Nicolaides;Nickolas Papadopoulos;Bo Liu

  • The transcriptional program in the response of human fibroblasts to serum.

    Vishwanath R. Iyer;Michael B. Eisen;Douglas T. Ross;Greg Schuler

  • Expression profiling using cdna microarrays

    David J Duggan;Michael Bittner;Yidong Chen;Paul Meltzer

  • Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry

    Andrew J. Maniotis;Robert Folberg;Angela Hess;Elisabeth A. Seftor

  • Gene-Expression Profiles in Hereditary Breast Cancer

    I Hedenfalk;D Duggan;Y Chen;M Radmacher

  • AIB1, a Steroid Receptor Coactivator Amplified in Breast and Ovarian Cancer

    Sarah L. Anzick;Juha Kononen;Robert L. Walker;David O. Azorsa

  • High frequency of BRAF mutations in nevi.

    Pamela M. Pollock;Ursula L. Harper;Katherine S. Hansen;Laura M. Yudt

  • Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

    Manfred Schwab;Kari Alitalo;Karl Heinz Klempnauer;Harold E. Varmus

  • Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma.

    Ashani T. Weeraratna;Yuan Jiang;Galen Hostetter;Kevin Rosenblatt

  • Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search

    Jeffrey R. Smith;Diha Freije;John D. Carpten;Henrik Grönberg;Henrik Grönberg

  • Microarrays and toxicology: the advent of toxicogenomics.

    Emile F. Nuwaysir;Michael Bittner;Jeffrey Trent;J. Carl Barrett

  • Identification of an Amplified, Highly Expressed Gene in a Human Glioma

    Kenneth W. Kinzler;Sandra H. Bigner;Darrell D. Bigner;Jeffrey M. Trent

  • HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome

    J.D. Carpten;C.M. Robbins;A. Villablanca;L. Forsberg

  • α-methylacyl-CoA racemase: A new molecular marker for prostate cancer

    Jun Luo;Shan Zha;Wesley R. Gage;Thomas A. Dunn

  • Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

    Kevin G. Becker;Richard M. Simon;Joan E. Bailey-Wilson;Boris Freidlin

  • Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.

    Susan L. Church;James W. Grant;Lisa A. Ridnour;Larry W. Oberley

  • Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.

    J. Carpten;N. Nupponen;S. Isaacs;R. Sood

Frequent Co-Authors

Paul S. Meltzer
Paul S. Meltzer National Institutes of Health
John D. Carpten
John D. Carpten University of Southern California
Jianfeng Xu
Jianfeng Xu Arkansas State University
William B. Isaacs
William B. Isaacs Johns Hopkins University
Joan E. Bailey-Wilson
Joan E. Bailey-Wilson National Institutes of Health
Elizabeth M. Gillanders
Elizabeth M. Gillanders National Institutes of Health
Xin Yuan Guan
Xin Yuan Guan University of Hong Kong
David Craig
David Craig University of Southern California
Kevin M. Brown
Kevin M. Brown National Institutes of Health
Edward R. Dougherty
Edward R. Dougherty Texas A&M University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying genetics opens doors to a wide range of careers in healthcare, research, and administration. For those looking to complement their genetics background or explore related fields, there are numerous affordable and flexible options available online.

If you are interested in the administrative side of healthcare, consider enrolling in online health administration programs or pursuing an online health management degree. These programs can provide management and leadership skills relevant to various healthcare settings.

For a clinical pathway that pairs well with genetics, some students opt for nursing programs easy to get into. Nursing offers hands-on patient care experience and a direct impact in healthcare delivery.

Those interested in allied health careers may also explore medical billing certification to access essential roles in healthcare operations. Each of these paths offers flexibility and growth, helping you build a tailored career after studying genetics.

Best Scientists Citing Jeffrey M. Trent

Trending Scientists

Recently Published Articles